Related references
Note: Only part of the references are listed.A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation
Marijana Vujkovic et al.
NATURE GENETICS (2022)
Current therapies and new developments in NASH
Jean-Francois Dufour et al.
GUT (2022)
Human hepatocyte PNPLA3-148M exacerbates rapid non-alcoholic fatty liver disease development in chimeric mice
Mohammad Kabbani et al.
CELL REPORTS (2022)
A web tool for the design of prime-editing guide RNAs
Ryan D. Chow et al.
NATURE BIOMEDICAL ENGINEERING (2021)
Establishment of human fetal hepatocyte organoids and CRISPR-Cas9-based gene knockin and knockout in organoid cultures from human liver
Delilah Hendriks et al.
NATURE PROTOCOLS (2021)
How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
Yana Geng et al.
HEPATOLOGY INTERNATIONAL (2021)
Diagnosis and management of secondary causes of steatohepatitis
Roman Liebe et al.
JOURNAL OF HEPATOLOGY (2021)
Therapeutic pipeline in nonalcoholic steatohepatitis
Raj Vuppalanchi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management
Amedeo Lonardo et al.
ADVANCES IN THERAPY (2021)
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Rohit Loomba et al.
CELL (2021)
Ablation of fatty acid desaturase 2 (FADS2) exacerbates hepatic triacylglycerol and cholesterol accumulation in polyunsaturated fatty acid-depleted mice
Yuri Hayashi et al.
FEBS LETTERS (2021)
FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption
Bethan L. Clifford et al.
CELL METABOLISM (2021)
Modeling PNPLA3-Associated NAFLD Using Human-Induced Pluripotent Stem Cells
Samantha G. Tilson et al.
HEPATOLOGY (2021)
Dietary carbohydrates and fats in nonalcoholic fatty liver disease
Hannele Yki-Jarvinen et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests
Mojgan Masoodi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
New targets for NAFLD
Lucia Parlati et al.
JHEP REPORTS (2021)
Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology
Mohammed Eslam et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Therapeutic landscape for NAFLD in 2020
Brent A. Neuschwander-Tetri
GASTROENTEROLOGY (2020)
Fast and efficient generation of knock-in human organoids using homology-independent CRISPR-Cas9 precision genome editing
Benedetta Artegiani et al.
NATURE CELL BIOLOGY (2020)
Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages
Sander Lefere et al.
JOURNAL OF HEPATOLOGY (2020)
Human Liver Spheroids as a Model to Study Aetiology and Treatment of Hepatic Fibrosis
Tracey Hurrell et al.
CELLS (2020)
Human Pluripotent Stem Cell-Derived Organoids as Models of Liver Disease
Muhammad Nadzim Bin Ramli et al.
GASTROENTEROLOGY (2020)
FGF19 and FGF21 for the Treatment of NASH-Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human
Emma Henriksson et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
CRISPR-Cas Tools and Their Application in Genetic Engineering of Human Stem Cells and Organoids
Delilah Hendriks et al.
CELL STEM CELL (2020)
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
Zobair Younossi et al.
HEPATOLOGY (2019)
Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis
Soumik BasuRay et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice
Daniel Linden et al.
MOLECULAR METABOLISM (2019)
Modeling Steatohepatitis in Humans with Pluripotent Stem Cell-Derived Organoids
Rie Ouchi et al.
CELL METABOLISM (2019)
Generation of Human Fatty Livers Using Custom-Engineered Induced Pluripotent Stem Cells with Modifiable SIRT1 Metabolism
Alexandra Collin de I'Hortet et al.
CELL METABOLISM (2019)
Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies
Norbert Stefan et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Search-and-replace genome editing without double-strand breaks or donor DNA
Andrew V. Anzalone et al.
NATURE (2019)
Non-alcoholic fatty liver disease - A global public health perspective
Zobair M. Younossi
JOURNAL OF HEPATOLOGY (2019)
Human PNPLA3-I148M variant increases hepatic retention of polyunsaturated fatty acids
Panu K. Luukkonen et al.
JCI INSIGHT (2019)
Metabolic Targets in Nonalcoholic Fatty Liver Disease
William P. Esler et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2019)
Human hepatic 3D spheroids as a model for steatosis and insulin resistance
Mikael Kozyra et al.
SCIENTIFIC REPORTS (2018)
Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids
Huili Hu et al.
CELL (2018)
Hepatic steatosis risk is partly driven by increased de novo lipogenesis following carbohydrate consumption
Francis W. B. Sanders et al.
GENOME BIOLOGY (2018)
Perilipins: a diversity of intracellular lipid droplet proteins
Hiroyuki Itabe et al.
LIPIDS IN HEALTH AND DISEASE (2017)
Animal Models of Nonalcoholic Fatty Liver Disease-A Starter's Guide
Mikhail A. Van Herck et al.
NUTRIENTS (2017)
Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation
Chai-Wan Kim et al.
CELL METABOLISM (2017)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
MS-DIAL: data-independent MS/MS deconvolution for comprehensive metabolome analysis
Hiroshi Tsugawa et al.
NATURE METHODS (2015)
Hypobetalipoproteinemia and abetalipoproteinemia
Francine K. Welty
CURRENT OPINION IN LIPIDOLOGY (2014)
Obesity resistance and deregulation of lipogenesis in Δ6-fatty acid desaturase (FADS2) deficiency
Wilhelm Stoffel et al.
EMBO REPORTS (2014)
Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease
Jennifer E. Lambert et al.
GASTROENTEROLOGY (2014)
Molecular interplay between Δ5/Δ6 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis
Cristina Lopez-Vicario et al.
GUT (2014)
Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study
Juanwen Zhang et al.
SCIENTIFIC REPORTS (2014)
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran et al.
NATURE PROTOCOLS (2013)
Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial
Helena Bjermo et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2012)
Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis
John Zhong Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro
Carlo Pirazzi et al.
JOURNAL OF HEPATOLOGY (2012)
The use of stable isotope-labeled glycerol and oleic acid to differentiate the hepatic functions of DGAT1 and-2
Jenson Qi et al.
JOURNAL OF LIPID RESEARCH (2012)
Secondary causes of nonalcoholic fatty liver disease
Jacob M. Kneeman et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2012)
Identification of a Therapeutic Strategy Targeting Amplified FGF19 in Liver Cancer by Oncogenomic Screening
Eric T. Sawey et al.
CANCER CELL (2011)
Patatin-Like Phospholipase Domain-Containing 3/Adiponutrin Deficiency in Mice Is Not Associated with Fatty Liver Disease
Weiqin Chen et al.
HEPATOLOGY (2010)
Lipidomics reveals a remarkable diversity of lipids in human plasma
Oswald Quehenberger et al.
JOURNAL OF LIPID RESEARCH (2010)
Hepatic Stearoyl-CoA Desaturase (SCD)-1 Activity and Diacylglycerol but Not Ceramide Concentrations Are Increased in the Nonalcoholic Human Fatty Liver
Anna Kotronen et al.
DIABETES (2009)
Common variants at 30 loci contribute to polygenic dyslipidemia
Sekar Kathiresan et al.
NATURE GENETICS (2009)
Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts
Yurii S. Aulchenko et al.
NATURE GENETICS (2009)
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Stefano Romeo et al.
NATURE GENETICS (2008)
Abetalipoproteinemia: two case reports and literature review
Rola Zamel et al.
ORPHANET JOURNAL OF RARE DISEASES (2008)
Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease
Harmeet Malhi et al.
SEMINARS IN LIVER DISEASE (2008)
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
T Inagaki et al.
CELL METABOLISM (2005)
Share Paper
